Nivatrotamab (Hu3F8-BsAb), a humanized anti-GD2/CD3 bispecific antibody and T-cell engager specific to CD3 and GD2, is employed in the study of neuroblastoma [1].
Target:
Integrin|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
